1,035 hedge funds and large institutions have $34.9B invested in Biogen in 2021 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 349 increasing their positions, 397 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

27% less call options, than puts

Call options by funds: $1.24B | Put options by funds: $1.7B

42% less first-time investments, than exits

New positions opened: 72 | Existing positions closed: 124

44% less funds holding in top 10

Funds holding in top 10: 2715 (-12)

Holders
1,035
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.24B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$195M
2 +$118M
3 +$113M
4
JP Morgan Chase
JP Morgan Chase
New York
+$70.9M
5
Amundi
Amundi
France
+$66.6M

Top Sellers

1 -$181M
2 -$117M
3 -$115M
4
Renaissance Technologies
Renaissance Technologies
New York
-$98.6M
5
Northern Trust
Northern Trust
Illinois
-$87.3M
Name Holding Trade Value Shares
Change
Change in
Stake
526
$886K
527
$881K
528
$877K
529
$875K
530
$869K
531
$861K
532
$855K
533
$850K
534
$848K
535
$841K
536
$838K
537
$834K
538
$829K
539
$828K
540
$825K
541
$825K
542
$812K
543
$803K
544
$801K
545
$799K
546
$798K
547
$791K
548
$791K
549
$787K
550
$786K